aDepartment of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK bDepartment of Rheumatology, Sheffield Teaching Hospitals NHS Foundation Trust, ...

The National Key Laboratory of Agricultural Microbiology, College of Life Science and Technology, College of Chemistry, Huazhong Agricultural University, Wuhan 430070, Hubei, China ...

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a formidable global health threat, afflicting nearly one-quarter of the world’s population. A complete understanding of the ...

Dr Fonseca shares findings from the MonumenTAL-1 trial presented at ASCO 2023, suggesting potentially reduced infection rates in patients with relapsed/refractory multiple myeloma receiving ...

Department of Emergency Medicine, Stanford University School of Medicine, Palo Alto, CA, USA Although cellular immunity has garnered much attention in the era of single-cell technologies, humoral ...

College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China Jinhua Institute of Zhejiang University, 403 Yongkang Street, Jinhua 321299, China Key Laboratory ...

Disparities in multiple myeloma: A global perspective on drug toxicity trends. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full text ...

The use of a monoclonal antibody that reduced circulating IgG levels, led to a decrease in preexisting neutralizing antibodies (NAbs) to adeno-associated virus (AAV). The study, which showed that this ...

Introduction: SARS-CoV-2 mRNA vaccinations elicit both virus-specific humoral and T-cell responses, but a complex interplay of different influencing factors, such as natural immunity, gender, and age, ...